Market revenue in 2023 | USD 949.9 million |
Market revenue in 2030 | USD 1,737.1 million |
Growth rate | 9% (CAGR from 2023 to 2030) |
Largest segment | Kits and consumables |
Fastest growing segment | Instruments |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Instruments, Kits and Consumables, Services |
Key market players worldwide | Qiagen NV, Illumina Inc, Becton Dickinson & Co, ANGLE PLC, Myriad Genetics Inc, Hologic Inc, Biocept Inc, Thermo Fisher Scientific Inc, Danaher Corp, Roche Holding AG, Guardant Health Inc, Exact Sciences Corp, Biodesix Inc Ordinary Shares, Epigenomics AG, OncoCyte Corp, Natera Inc, Personalis Inc, Labcorp Holdings Inc, Helio Health |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to cancer biopsy market will help companies and investors design strategic landscapes.
Kits and consumables was the largest segment with a revenue share of 60.96% in 2023. Horizon Databook has segmented the Brazil cancer biopsy market based on instruments, kits and consumables, services covering the revenue growth of each sub-segment from 2018 to 2030.
Horizon Databook provides a detailed overview of country-level data and insights on the Brazil cancer biopsy market , including forecasts for subscribers. This country databook contains high-level insights into Brazil cancer biopsy market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account